Tag: Novo Nordisk
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a challenge researchers have wrestled with since...
World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®
In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...
Novo Nordisk Hit by an IT Security Breach: Pharma Giant Confronts Cyber Threats
Novo Nordisk (Novo Nordisk A/S) the Danish multinational pharmaceutical major, earlier this week announced that the company had identified an IT security incident involving unauthorised access to a limited number of internal IT...
Novo Nordisk’s Etavopivat Cracks Phase 3 Goals: A Potential New Standard of Care for Sickle Cell Disease
Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...
